← Back to Search

App for Monitoring Chemotherapy Side Effects in Breast Cancer

N/A
Recruiting
Research Sponsored by Julie Lemieux
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is aimed at exploring the use of a web-based patient portal to improve the monitoring of oral therapy toxicities in breast cancer patients.

Who is the study for?
This trial is for adults over 18 with metastatic breast cancer who are currently taking oral chemotherapy drugs like palbociclib, everolimus, or capecitabine. Participants need to have a smartphone, tablet, or computer. Those with cognitive impairments cannot join.Check my eligibility
What is being tested?
The study is testing an app designed to help patients self-report side effects from oral chemotherapy treatments. The goal is to see if this can improve patient care and safety by providing systematic monitoring outside of the hospital setting.See study design
What are the potential side effects?
While not directly related to the app being tested, the oral chemotherapies involved may cause side effects such as nausea, fatigue, diarrhea, low blood cell counts leading to increased infection risk and other specific drug-related toxicities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of calls

Trial Design

1Treatment groups
Experimental Treatment
Group I: ApplicationExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Julie LemieuxLead Sponsor

Media Library

Application Clinical Trial Eligibility Overview. Trial Name: NCT05743686 — N/A
Breast Cancer Research Study Groups: Application
Breast Cancer Clinical Trial 2023: Application Highlights & Side Effects. Trial Name: NCT05743686 — N/A
Application 2023 Treatment Timeline for Medical Study. Trial Name: NCT05743686 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for enrollment in this research endeavor?

"Clinicaltrials.gov confirms that this medical examination is actively enrolling volunteers, with the first post being made on January 16th 2023 and the last edit occurring on February 15th 2023."

Answered by AI

How many participants have been included in this experiment?

"Affirmative. According to records on clinicaltrials.gov, the trial which was initially posted in January 16th 2023 is still open for recruitment with 30 potential participants required at a single location."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
St-Sacrement Hospital
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
Recent research and studies
clinicaltrials.govStudy
App for Adverse Events to Oral Chemotherapy - Pilot Study
Julie Lemieux 2023. "App for Adverse Events to Oral Chemotherapy - Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05743686.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top